Previous Close | 0.1410 |
Open | 0.1514 |
Bid | 0.1248 x N/A |
Ask | 0.1476 x N/A |
Day's Range | 0.1326 - 0.1854 |
52 Week Range | 0.0745 - 5.0000 |
Volume | |
Avg. Volume | 887 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Kintara (KTRA) inks a definitive merger agreement with TuHURA for an all-stock transaction. It is expected to close in the third quarter of 2024. The stock surges 63.4%.
Kintara (KTRA) receives a $2 million grant from the National Institutes of Health to develop its breast cancer treatment candidate, REM-001. The stock surges 41%.